We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current TCRT market cap is 3.15M. The company's latest EPS is USD -21.9453 and P/E is -0.09.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 54k | 1,000 | 5k | 0 |
| Operating Income | -8.67M | -7.95M | -1.74M | -1.17M | -1.15M |
| Net Income | -8.48M | -7.84M | -1.68M | -1.13M | -1.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 398k | 2.92M | 303k |
| Operating Income | -57.86M | -80.36M | -78.75M | -35.24M | -34.27M |
| Net Income | -117.8M | -79.98M | -78.75M | -37.73M | -35.14M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.44M | 8.26M | 6.04M | 4.68M | 3.55M |
| Total Liabilities | 5.54M | 1.96M | 1.24M | 907k | 826k |
| Total Equity | 13.9M | 6.31M | 4.8M | 3.77M | 2.72M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 109.11M | 146.35M | 94.87M | 64.94M | 8.26M |
| Total Liabilities | 14.1M | 22.36M | 36.81M | 26.38M | 1.96M |
| Total Equity | 95.01M | 123.98M | 58.06M | 38.56M | 6.31M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -22.76M | -30.14M | -1.92M | -3.6M | -4.38M |
| Investing | -157k | 1.35M | N/A | N/A | N/A |
| Financing | -18.14M | -18.14M | N/A | N/A | N/A |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -40.85M | -57.01M | -61.47M | -29.23M | -30.14M |
| Investing | -284k | -9.78M | -3.32M | -193k | 1.35M |
| Financing | 59.15M | 102.12M | 25.78M | 6.37M | -18.14M |
| Market Cap | 3.15M |
| Price to Earnings Ratio | -0.09 |
| Price to Sales Ratio | 10.41 |
| Price to Cash Ratio | 0.52 |
| Price to Book Ratio | 0.5 |
| Dividend Yield | - |
| Shares Outstanding | 1.6M |
| Average Volume (1 week) | 73.37k |
| Average Volume (1 Month) | 29.15k |
| 52 Week Change | -82.54% |
| 52 Week High | 32.85 |
| 52 Week Low | 1.63 |
| Spread (Intraday) | 0.4 (17.39%) |
| Company Name | Alaunos Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.ziopharm.com |
| Industry | spec outpatient facility,nec (8093) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
